Living kidney donation rates are increasing in the United States and internationally. Major consensus statements on the care of living kidney donors recommend communicating all potential health and psychosocial risks to donors. We evaluated the degree of international variation in the process of informed consent of potential donors during their evaluation.
donors. Additionally, the financial and psychosocial costs associated with being a living donor were inconsistently communicated to donors during the informed consent process.
Compared to non-US respondents, US respondents were more likely to use written material and visual aids to convey risks to donors, have mandatory psychosocial evaluations, and provide access to donor support groups. US transplant centers were also more likely to discuss the possibility of the donor needing dialysis or a transplant if their remaining kidney fails in the future, possible travel expenses and loss of work income due to donation recovery. Conversely, the US respondents' centers were less likely to offer long-term follow up and to utilize nephrologists to obtain written donor consent for donation.
As dependence on living organ donation increases best practices for informed consent, donor evaluation and uniform risk conveyance need to be established. This may be accomplished by using a model informed consent template to ensure that informed consent from donors is consistently obtained. 
INTRODUCTION
Due to the shortage of deceased donor kidneys and the increasing use of living donor kidneys from non-related and expanded criteria kidney donors [1] [2] [3] , almost half of all kidneys donated in the United States come from living donors and the rates of living kidney donation internationally continue to increase. 3, 4 The fundamental premise of living kidney transplantation is that the benefits to the recipient and potential psychosocial benefits to the donor significantly outweigh the possible health risks to the donor. The long term benefits for the recipient of transplantation of a kidney from a living donor are significantly better than the benefits of cadaveric transplantation.
5
Despite the improved outcomes for recipients living donor kidney transplantation challenges the core medical ethics principle, "first do no harm."
However, to date, the lack of a national registry, which would track all kidney donation outcomes, limits comprehensive understanding of the donor's medical, financial and psychosocial risks. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Although the risks of living kidney donation appear to be minimal, as with any major surgery there are some risks of donation. 16 
METHODS

SURVEY DESIGN AND CONTENT
In order to design a comprehensive survey that was easy to complete, a thorough review of the literature regarding living kidney donation was performed. 
RESPONDENTS
In order to solicit a broad range and large sample of transplant professionals, we In order to recruit survey participants, we decided individuals would be most likely to complete surveys when registering onsite for the conference. Distributing the surveys in the conference registration area allowed us to have a one on one conversation with conference attendees in order to assess whether they were involved with living kidney transplantation, in particular if they were involved in donor evaluation or management. If they stated they worked with living kidney donors, they were invited to fill out the survey. With the help of the conference administrators we were able to provide participants with a table on which to fill the survey out and pencils for doing so.
If the participant stated they wanted more time to fill out the survey, they were instructed to fill it out at their leisure and to return it in any of six drop boxes located throughout the conference venue or to mail or fax the survey to us after they had completed it.
In addition to recruiting survey participants during onsite registration, we also provided surveys to individuals attending any conference lectures having to do with living kidney donation. In such instances individuals were instructed that they could return their surveys at the end of the lecture in a box placed outside the lecture room or in any of the drop boxes located throughout the venue. Alternatively, as with those individuals recruited at registration, they were told they could return the surveys via mail or fax. These two recruitment methods were employed to enable a representative sample of conference attendees involved in living kidney donation to be surveyed. In both cases, the respondents were not given any form of compensation.
Consent for study participation was presumed upon returning the survey. An information sheet provided with the survey explained the purpose of the study and indicated that all responses would be confidential. Permission to distribute the survey at the WTC was obtained from the Conference Planning Committee prior to the conference.
DATA COLLECTION
The surveys were returned in containers located throughout the conference center.
The survey also included instructions to mail or fax surveys back to us after the conference. Of the 223 complete surveys we recovered, 220 were returned at the conference, two were received by mail and one by fax. Two of the surveys returned could not be used in the analysis, because only demographic data were provided. Five surveys did not include country of origin and so could not be used in the comparative analysis.
Thus the analysis was done using 216 surveys. Each survey was assigned a unique number in order to make the data confidential and the responses were entered into an Excel spreadsheet. The data were checked independently by two people for any typographical or data entry errors.
STATISTICAL ANALYSIS
Standard descriptive statistics were computed for all variables. To assess differences between US and non-US respondents, chi-square tests were used for dichotomous variables and the Wilcoxon Rank-Sum test was used for ordinal variables.
In cases where there were a small number of observations for dichotomous outcomes,
Fisher's exact test was used. Variables are listed in Table 3 and Table 4 along with the results. Respondents from the same transplant center were treated independently such that some centers may be represented greater than others (Table 1 ). All analyses were based on the respondent, not on the transplant center. All analyses were conducted using SAS 9.1 (SAS Institute Inc., Cary, NC, USA).
RESULTS
RESPONDENTS DEMOGRAPHICS & TIME SPENT INTERACTING WITH DONORS
The survey respondents (n=216) represented 40 countries and 177 transplant centers. 48% (n=104) of the respondents were from US centers, representing 79 centers from 29 states ( Table 1 ). The number of respondents from the various states ranged from 1 (8 states) to 13 (PA); the number of centers per state represented ranged from 1 (11 states) to 11 (PA). The 112 participants from the other countries represented 98 centers.
The number of participants per country ranged from 1 (16 countries) to 15 (UK). The number centers per country represented ranged from 1 (15 countries) to 11 (UK). 
15 (7) 11 (6) The majority of the survey respondents were physicians (78%) and nurses (11%).
38% of the respondents were nephrologists and 28% were transplant surgeons. 14% of the respondents were transplant coordinators. Compared to non-US respondents, more US transplant coordinators (26% v. 6%, p<0.001) and non-MDs (29% v. 10%, p<0.001) completed the survey than their counterparts outside of the US (Table 2) .
Most respondents (74%) spent greater than 20% of their time with living kidney donors, with over a third of respondents (38%) spending greater than 70% of their time with living kidney donors. Additionally, about a quarter of respondents (24%) was either the chairperson or director of their transplant programs. US versus non-US respondents did not differ in the nature or quantity of interactions with donors in the past year (Table   2 ). Together the respondents interacted with over 10,500 potential donors per year. Fewer respondents discussed specific financial risks with potential donors. Of the five specific financial costs that donors may face that we listed, on average 41% of respondents did not discuss the specific cost. Approximately two thirds of respondents did discuss loss of salary, travel costs and family care costs, whereas increased costs of health insurance and rehabilitation were discussed by a little more than half of the respondents. When the costs were discussed there was again great variability regarding whether donors were told there would be no significant cost, or whether there were costs associated with donation. For example, with regards to the costs of family care during the donation process, 27% of respondents told donors there was no increased cost, 33% told donors there was an increased cost and 39% of respondents did not discuss the cost at all.
Although 78% of respondents discussed the potential of future improved psychosocial well being with their prospective donors (17% not discussed, 5 % stated improved psychosocial well being was not likely), they were less likely to inform donors about potentially negative psychosocial outcomes. For example, over a quarter of US respondents did not discuss the potentially stressful nature of transplant (27%, not discussed), the possibility of post-operative depression (24%) or suicidal ideation (36%), or the possibility of adverse effects to the donor's marital or family life (23%). If psychosocial risks were discussed, some health professionals told living donors that they
were not likely to have these issues arise in their situation while others told donors that these risks were somewhat likely. For example, while 30% of respondents told potential donors that adverse effects on their marital/family life would not be likely, 48% of respondents stated that such risks were likely.
Exploring differences in what risks were communicated to potential donors at US and non-US transplant centers, US transplant professionals were more likely to communicate to potential donors that they might have to go on dialysis or receive a transplant if their remaining kidney failed (57% v. 36%; p =0.01), to discuss with donors that they may have to pay travel costs to the transplant centers (63% v. 35%; p=0.001) and discuss possible lost income while they recovered (59% v. 40%; p=0.01). There were no significant differences in the conveyance of psychosocial risks between US and non-US respondents. (29) 7 (7) 72 (69) 19 (18) 14 (14) 0.12
Premature Cardio Vascular Disease 197 60 (64) 25 (27) 9 (10) 61 (59) 31 (30) 11 (11) 0.80
Chronic Kidney Disease 196 35 (38) 54 (59) 3 (3) 43 (41) 55 (53) 6 (6) (47) 22 (30) 32 (36) 43 (48) 15 (17) 0.07 * We did not define any of the medical risks in the survey.
CONSENSUS BUILDING, PRACTICE TRANSLATION
Finally, most (82%) respondents reported that they believe their center would be willing to adopt a centralized informed consent template. More non-US transplant professionals, said they would be willing to adopt such a template as compared to the US respondents (84% v. 79%; p =0.001).
DISCUSSION
This study, an international study on informed consent practices during donor evaluation, reveals that the risks communicated to donors and the informed consent process vary considerably across transplant professionals, centers and countries. For a potential donor to truly make an informed choice whether to donate their kidney they must understand the medical, financial and psychosocial risks they face as compared to the alternative of not donating their kidney. Patients also need sufficient time to have a conversation with a health professional, to have risk percentages explained in a way that makes sense to them, to have education tailored to their level of health literacy, to be provided with additional materials to take home with them to review and discuss with their family members, and to be provided with ample opportunity to ask any questions the may have about the process of donation and risks associated with it.
VARIATION IN RISKS CONVEYED
This study uncovered several important problems that need to be addressed to improve the living donor informed consent process. First, information about the medical risks that a potential donor may face is presented to donors at some transplant centers inaccurately. We found, for example, that while 56% of practitioners told potential donors they had an increased risk of developing ESRD, 40% said that there was no increased risk or did not discuss the risk at all. Most research available to date indicates that while GFR does decrease following uninephrectomy, the likelihood of ESRD requiring dialysis increases only slightly. 3, 11, 12 Some research does indicate that the risk of ESRD does not increase after donation. 10, 27, 28 Although the variation in what risks are conveyed to the reader is probably due to the debate still occurring about what the actual risks to a living donor are, the result is that potential donors are making donation decisions based on different risk information depending on the center in which they undergo transplant evaluation.
Second, discussion of financial and psychosocial outcomes does not always occur and the conclusions drawn by transplant professionals summarizing the current research are inconsistent. In this study, and in others, information about financial and psychosocial risks to the donor was left out about by at least 30% of respondents. 25 Even when discussed, the information communicated to donors varied. For example, although some research indicates that most donors are satisfied with their donation decision, current research also consistently shows that worsened familial relations are a possible but unlikely risk associated with donating a kidney (2 -13%). 14, 19, 29, 30 However, we found that while a large percentage of practitioners communicated to donors that donation may negatively affect familial life, many either inform donors that such effects are not likely or do not discuss this potential risk at all. Similarly, while most respondents discussed the potential improved psychosocial status of donors, many did not discuss the risk of donor regret, depression or recollection of the surgery as a traumatic experience.
Evidence for some risk of these negative psychosocial consequences can be found in the scientific literature surrounding living kidney donation. Mandatory psychosocial evaluation varied significantly between US and non-US centers despite an international consensus that psychosocial evaluations are necessary. 21, 22, 24, 25, 32, 33 Given the lack of medical benefit to the donor, living kidney donation continues to spark controversy -within the family, ethicists worry about coercion and with anonymous donation, ethicists worry about the psychological stability of the donor; thus a thorough psychosocial evaluation of potential donors is essential in ensuring donors are in fact making autonomous decisions. 17 Given the recent increase in nonrelated donations, and evidence that such evaluations can effectively rule out psychopathology amongst anonymous donors, this step in the evaluation process should become standard in all countries. 22, 26, [34] [35] [36] [37] Regarding country variation in informed consent processes, it is not clear why US centers would be more likely to send donors written information prior to donor evaluation as compared to international transplant centers. However, evidence indicates that having written material available for donor education prior to donation makes donors more comfortable with donation. 38 Thus, consistently providing written materials to potential donors may significantly improve the informed consent process. Receiving written material prior to actual evaluation may also lead to increased donation.
Additionally it is not immediately evident why non-US centers would be more likely to use specific organ donation consent forms, whereas US centers use more general surgical consent forms. Perhaps this variation is a result of the US being a more litigious society and hence less willing to modify basic written forms that have already been deemed appropriate by the legal system. Alternatively, it could be because as our data indicates, in the US surgeons are more likely to be responsible for informed consent and perhaps surgeons are more likely to prefer uniform consent forms for all their surgeries.
Finally, regarding donor follow up, the finding that US centers are less likely to offer long term follow up for donors may be due to different government policies. The availability of national health insurance schemes in other countries may facilitate such follow up for donors. It is not as clear why non-US centers would be less likely to offer support groups; however, cultural differences may explain this variation. For example, in most non-Western cultures, patients commonly rely on family members for assistance with self-care management rather than rely primarily on themselves for their care. 39, 40 On the other hand, American health care expects patients to be self reliant after medical procedures. 41 Accordingly, patients in the US may experience additional stress until they are fully recovered and thus, may be more amenable to finding comfort in support groups. While these variations in follow-up and long-term support exist and may be explained by political and/or cultural differences, there is some evidence that donors, everywhere, would benefit from access to both long term care and support groups. 42 Furthermore, long-term care and follow up will lead to an increase in kidney donation in two ways. First, potential donors may be more willing to donate if they are assured that the transplant center will provide them with long-term care. Second, because of the concerns recipients have for donors, potential recipients may become more willing to accept kidneys from living donors if they are assured that transplant centers will treat the health sequelae that result from donating the kidney. Organ Sharing), outlines specific elements that transplant centers must fulfill during the informed consent process. This should limit the variability in informed consent processes that were evident in this survey for US transplant centers. However, follow up surveys of practices must be conducted to ensure this occurs.
STUDY STRENGTHS AND LIMITATIONS
There were several limitations to our study. First, the survey was only available in 
RECOMMENDATIONS:
In summary, the variation in donor informed consent found in this study may be occurring as a function of not having definitive information about what risks donors face or due to the increasing pressures of increasing organ availability conflicting with the ethical obligations of providing complete donor information. Most likely, the variations in practices are a result of a combination of these two. Our study reinforces and further develops previous articles that have also indicated significant geographic variation in informed consent practices. 45, 46 We recommend establishing international practice guidelines for informed consent of living kidney donors. According to our survey results, there is significant interest in a 
